Previous Article | Next Article ![]()
Mol Cell Biol, July 1998, p. 3862-3870, Vol. 18, No. 7
Department of Physiology and Biophysics, The
University of Iowa, Iowa City, Iowa 52242-1109
Received 17 October 1997/Returned for modification 22 December
1997/Accepted 6 April 1998
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Inhibition of Clathrin-Mediated Endocytosis
Selectively Attenuates Specific Insulin Receptor Signal
Transduction Pathways
SUMMARY
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
ACKNOWLEDGMENTS
REFERENCES
SUMMARY
|
|
|---|
To examine the role of clathrin-dependent insulin receptor internalization in insulin-stimulated signal transduction events, we expressed a dominant-interfering mutant of dynamin (K44A/dynamin) by using a recombinant adenovirus in the H4IIE hepatoma and 3T3L1 adipocyte cell lines. Expression of K44A/dynamin inhibited endocytosis of the insulin receptor as determined by both cell surface radioligand binding and trypsin protection analysis. The inhibition of the insulin receptor endocytosis had no effect on either the extent of insulin receptor autophosphorylation or insulin receptor substrate 1 (IRS1) tyrosine phosphorylation. In contrast, expression of K44A/dynamin partially inhibited insulin-stimulated Shc tyrosine phosphorylation and activation of the mitogen-activated protein kinases ERK1 and -2. Although there was an approximately 50% decrease in the insulin-stimulated activation of the phosphatidylinositol 3-kinase associated with IRS1, insulin-stimulated Akt kinase phosphorylation and activation were unaffected. The expression of K44A/dynamin increased the basal rate of amino acid transport, which was additive with the effect of insulin but had no effect on the basal or insulin-stimulated DNA synthesis. In 3T3L1 adipocytes, expression of K44A/dynamin increased the basal rate of glucose uptake, glycogen synthesis, and lipogenesis without any significant effect on insulin stimulation. Together, these data demonstrate that the acute actions of insulin are largely independent of insulin receptor endocytosis and are initiated by activation of the plasma membrane-localized insulin receptor.
INTRODUCTION
|
|
|---|
Receptor-mediated endocytosis is an essential mechanism for several important physiological processes. These include down regulation of cell surface receptors, degradation of the receptor and/or ligand, absorption and retention of essential nutrients, transcellular transport of specific ligands, and the activation of intracellular signal transduction cascades (42, 49, 52). It is well established that the insulin receptor undergoes endocytosis upon insulin stimulation (3, 28, 35, 37); however, the exact physiological significance of insulin receptor internalization is poorly understood. Several studies have demonstrated that following insulin stimulation, the endosome-localized insulin receptor exhibits increased autophosphorylating and exogenous substrate tyrosine kinase activity compared to plasma membrane-associated insulin receptors (3, 31, 32). Based on the time course of endosome association, kinase activation, and compartmentalization of effector substrates, it has been hypothesized that the internalized endosome-associated insulin receptor population is responsible for the activation of intracellular signaling pathways (12, 18, 31). However, other studies have reported that low-temperature (4°C) blockade of insulin receptor internalization does not impair either insulin receptor autophosphorylation or tyrosine phosphorylation of the major insulin receptor substrate, IRS1 (9, 26). Thus, in contrast, these data suggest that activation of the plasma membrane-associated insulin receptor may be sufficient for, at least, the initial or proximal insulin-specific signaling events.
Considerable effort has been made to identify the structural
determinants responsible for insulin receptor internalization. Based on
expression of various insulin receptor mutants in fibroblasts, it has
been suggested that the insulin receptor is localized to microvillus
regions of the cell surface by both a dileucine motif present in the
juxtamembrane region of the
subunit and a downstream tyrosine-based
motif (2, 4, 5, 24, 25). These domains also appear to be
required for the segregation of the insulin receptor into
clathrin-coated pit regions. However, in addition to clathrin-mediated
internalization, the insulin receptor has also been reported to undergo
internalization through a clathrin-independent pathway (40, 50,
51). Although the insulin receptor kinase activity is required
for ligand-stimulated internalization, the identity and function of
tyrosine phosphorylation remain elusive, with evidence both for and
against the juxtamembrane GPLY and NPEY tyrosine-based motifs (2,
5, 7, 8, 13, 29).
Recently, substantial progress has been made in our understanding of
clathrin-mediated internalization and vesicle formation for
constitutively recycling, growth factor, and G-protein-coupled receptors (16, 58, 67). One essential protein in coated vesicle formation is the GTPase dynamin. Dynamin was first cloned from
the shibire temperature-sensitive paralytic Drosophila
melanogaster mutant and was subsequently found to be involved in
synaptic membrane vesicle recycling (22, 45). Dynamin
appears to be recruited to clathrin-coated pits, where its intrinsic
GTPase activity is required for the formation of clathrin-coated
vesicles (15, 39, 41, 56). Inhibition of dynamin function,
by expression of a dominant-interfering mutant (K44A/dynamin), prevents
coated-vesicle formation and internalization of transferrin, epidermal
growth factor, and
-adrenergic receptors (16, 58, 67).
Thus, to assess the functional role of dynamin in insulin receptor
endocytosis and insulin receptor-dependent downstream signaling, we
have prepared a recombinant adenovirus expressing the
dominant-interfering K44A/dynamin mutant. In this study, we demonstrate
that expression of K44A/dynamin inhibits internalization of the insulin
receptor without any significant effect on insulin-stimulated receptor
autophosphorylation, signaling to IRS1 or Akt, amino acid uptake, DNA
synthesis, glucose transport, lipogenesis, and glycogen synthesis. In
contrast, Shc phosphorylation and activation of mitogen-activated
protein kinase and phosphatidylinositol 3-kinase (PI 3-kinase) were
partially inhibited.
MATERIALS AND METHODS
|
|
|---|
Materials.
The cDNA encoding K44A/dynamin was a gift from
Sandra Schmid (Scripps, La Jolla, Calif.), and the LacZ recombinant
adenovirus was a gift of Chris Newgard (Southwestern University of
Texas, Dallas). [125I]insulin and
[125I]transferrin were purchased from New England Nuclear
(Boston, Mass.). [14C]aminoisobutyric acid
([14C]AIB), [U-14C]glucose,
[
-32P]ATP, and
2-deoxy-D-[1-3H]glucose were obtained from
Amersham (Arlington Heights, Ill.). [methyl-3H]glucose was purchased from ICN
(Costa Mesa, Calif.). The source of each antibody is indicated in the
descriptions of the specific methods below and/or the appropriate
figure legends. Protein G+-agarose and protein A-agarose
were purchased from Santa Cruz Biotechnology (Santa Cruz, Calif.).
Polyvinylidene difluoride (PVDF) membrane filters were purchased from
Millipore (Bedford, Mass.). Silica plates were purchased from Analtech
(Neward, Del.). All other reagents were obtained from Sigma Chemical
Co. (St. Louis, Mo.).
Cell culture and infection. The rat hepatoma H4IIE cell line was maintained in Dulbecco's modified Eagle's medium (DMEM) containing 25 mM glucose, 10% fetal bovine serum, 10% calf serum, 2 mM glutamine, penicillin (100 U/ml) and streptomycin (100 U/ml) and grown at 37°C in a 5% CO2 atmosphere. Confluent dishes of cells were infected with the recombinant adenoviruses for 1 h at 37°C. Following infection, the adenovirus was removed from the cells and replaced with growth medium. The infected hepatocytes were used for experimentation 36 to 48 h later.
The growth and differentiation of 3T3L1 adipocytes were performed as described previously (48). Tissue culture dishes containing 90 to 95% fully differentiated adipocytes were incubated at 37°C in 5% CO2 atmosphere in the continuous presence of the recombinant adenoviruses for 40 to 48 h. Under these conditions, the adipocytes demonstrated greater than a 95% infection and expression efficiency.Preparation of recombinant adenoviruses.
The K44A/dynamin
adenovirus was constructed by previously described methods
(6). Briefly, the K44A/dynamin was introduced into the
pACCMV vector via 5' BamHI and 3' HindIII
sites. The K44A/dynamin pACCMV and pJM17 cDNAs were cotransfected into
HEK293 cells by calcium phosphate precipitation. Lysates were harvested and serially diluted, and a single virus was plaque isolated. Large-scale productions of the K44A/dynamin and LacZ recombinant adenoviruses were prepared by infecting 85 to 90% confluent HEK293 cells with 1 ml of concentrated adenovirus in 15 ml of growth medium
(DMEM containing 10% fetal bovine serum, 10 mM HEPES [pH 7.4], 2 mM
glutamine, penicillin [100 U/ml], and streptomycin [100 U/ml]) for
1 h. The adenovirus-containing medium was then replaced with
growth medium. The cells were maintained at 37°C in 5%
CO2 for 48 h, after which the cell medium and
concentrated cell lysate were collected separately, and the adenovirus
stocks were stored at
20°C. H4IIE cells were infected with the
adenovirus medium, and 3T3L1 adipocytes were infected with the
concentrated cell lysate. The appropriate adenovirus titer was
determined for each cell line by assessing the adenovirus
concentration-dependent inhibition of [125I]transferrin
internalization. In all experiments, the minimum concentration required
for maximal inhibition of transferrin internalization was used.
Receptor internalization by radioligand binding. The internalization of the transferrin and insulin receptors was determined by the amount of acid-dissociable prebound ligand as described by Lamb et al. (36). Briefly, 35-mm-diameter dishes of infected H4IIE cells were incubated with either [125I]transferrin (3 nM; 1 µCi/µg) or [125I]insulin (0.02 nM, 375 µCi/µg) at 4°C for 3 or 4 h, respectively. Unbound ligands were removed, and internalization was initiated by washing the cells with serum-free medium at 37°C. At various times, endocytosis was blocked by washing the cells three times with ice-cold phosphate-buffered saline (PBS). The amount of acid-dissociable ligand (cell surface exposed) was determined by two consecutive incubations with 1.5 and 1.0 ml of stripping buffer (0.5 M NaCl, 0.2 M acetic acid) for 8 min each. The amount of intracellular ligand (internalized) was determined by detergent solubilization (1% sodium dodecyl sulfate [SDS]) of the acid-stripped cells. External and internal associated radioligands were measured by counting the two fractions on a Packard Autogamma 5000 counter.
Receptor internalization by trypsinization.
Insulin receptor
internalization was determined by measuring the percentage of receptors
that were resistant to trypsinization. Briefly, infected dishes of
H4IIE cells were washed twice with PBS and incubated with serum-free
DMEM for 3 h. The cells were incubated at 37°C in the absence or
presence of 100 nM insulin for the indicated period of time. After
insulin incubation, the cells were washed twice and incubated on ice
for 3 min with ice-cold, acidified DMEM (pH 4.0) containing 1% bovine
serum albumin. The cells were washed with ice-cold PBS and incubated
with trypsin (1 mg/ml in PBS [pH 7.4]) in ice water for 30 min with
occasional rocking. The reaction was stopped by addition of soybean
trypsin inhibitor (5 mg/ml), bacitracin (1 mg/ml), 2 mM
N-ethylmaleimide, and 2 mM phenylmethylsulfonyl fluoride. In
parallel, mock-treated cells were incubated with the stopping solution
for 30 min. Cells were then solubilized in lysis buffer (150 mM NaCl,
1% Nonidet P-40, 0.5% deoxycholate, 0.1% SDS, 50 mM Tris [pH 7.4],
10 mM sodium pyrophosphate, 100 mM NaF, 2 mM phenylmethylsulfonyl
fluoride, 2 mM sodium vanadate, 2 mM pepstatin, 1 µg of aprotinin per
ml, 10 µM leupeptin) for 10 min at 4°C. The cell lysates were
resuspended, subjected to SDS-polyacrylamide gel electrophoresis (PAGE)
under nonreducing conditions, and immunoblotted with an insulin
receptor
-subunit antibody (Transduction Laboratories, Lexington,
Ky.). The band corresponding to the 400-kDa
2
2 holoinsulin receptor was quantitated
by using Adobe Photoshop and NIH Image software.
Preparation of whole-cell detergent lysates.
H4IIE cells
were washed two times with PBS (pH 7.4) and incubated for 3 to 4 h
in serum-free medium. The cells were then treated with 100 nM insulin
for various times as indicated in the figure legends. Insulin
stimulation was terminated by two washes with ice-cold PBS (pH 7.4),
removal of excess liquid by aspiration, addition of liquid nitrogen to
the tissue culture plates, and storage at
80°C until used. The
snap-frozen cells were extracted in ice-cold lysis buffer (50 mM HEPES,
1% Triton X-100, 2.5 mM EDTA, 100 mM NaF, 10 mM
Na4P2O7 [pH 7.8], 1 µM
phenylmethylsulfonyl fluoride, 2 µM Na3VO4, 1 µg of aprotinin per ml, 10 µM leupeptin, 1 µM pepstatin A) by
rotation for 10 min at 4°C. Insoluble material was separated from the
soluble extract by microcentrifugation for 10 min at 4°C. Protein
concentration was determined by Bradford assay (Bio-Rad, Hercules,
Calif.).
Immunoprecipitation. The solubilized cell lysates were incubated at 4°C under constant rotation with either 5 µg of an insulin receptor polyclonal antibody (Upstate Biotechnology, Inc., Lake Placid, N.Y.), 4 µg of an IRS1 polyclonal antibody (Santa Cruz), or 4 µg of a Shc polyclonal antibody (Transducation Laboratories), followed by a 1-h incubation with protein G+-agarose (Santa Cruz). The immunoprecipitates were then eluted and subjected to SDS-PAGE and immunoblotting as described below.
Immunoblot analysis. Whole-cell lysates or the specific immunoprecipitates were subjected to reducing SDS-PAGE on either 7.5% acrylamide gels (insulin receptor and IRS1) or 10% acrylamide gels (hemagglutinin epitope [HA]-tagged K44A/dynamin, Shc, ERK1/2, and Akt). The resolved proteins were then transferred to PVDF filter membranes and subjected to immunoblot analysis as recommended by the manufacturer (Millipore).
PI 3-kinase assays.
PI 3-kinase activity measurements were
determined as described by Turinsky et al. (55). Briefly,
cells lysates were immunoprecipitated with either a phosphotyrosine
antibody conjugated to agarose (PT-66; Sigma) or the IRS1 antibody
followed by incubation with protein G+-agarose. The
immunoprecipitated lipid kinase activity was assessed by incubation
with 40 µCi of [
-32P]ATP plus 20 µg of
phosphatidylinositol (Avanti Polar Lipids, Birmingham, Ala.) for 15 min
at room temperature. The phosphorylated lipids were separated by
thin-layer chromatography, visualized by autoradiography, and
quantitated by scraping and counting the radiolabeled phosphoinositides
in a Packard scintillation counter.
Akt protein kinase activity.
Akt protein kinase activity was
determined as described by Moule et al. (44). Briefly, cell
lysates were prepared, and Akt was immunoprecipitated with a polyclonal
Akt antibody (Santa Cruz). Protein kinase activity was assessed by
incubation of the immunoprecipitates with 20 µCi of
[
-32P]ATP and 0.5 mg of histone H2B (Boehringer
Mannheim, Indianapolis, Ind.) per ml for 20 min at 30°C. The extent
of histone H2B phosphorylation was determined by separation on an
SDS-16% acrylamide gel, autoradiography and quantitation by excision
of the radiolabeled band, and counting in a Packard scintillation
counter. The amount of 32P incorporation was normalized for
the amount of Akt protein immunoprecipitated as determined by
densitometric scanning of Akt immunoblots.
Amino acid uptake. H4IIE cells were incubated in serum-free medium for 3 h at 37°C prior to a second incubation in the absence or presence of 100 nM insulin for 4 h as described by Krett et al. (34). The medium was then replaced with fresh serum-free medium containing 0.5 µCi of [14C]AIB (51 mCi/mmol) and incubated for 1 h at 37°C. Uptake was terminated by washing the cells three times with ice-cold PBS followed by solubilization with 1 ml of 1 N NaOH. The solubilized cells were assayed for protein content, mixed with scintillation fluid (Budget-Solve; RPI Corp., Mount Prospect, Ill.), and counted in a Packard scintillation counter.
Incorporation of [3H]thymidine into DNA. Confluent H4IIE cells were infected with adenovirus as described above. After infection for 1 h, the adenovirus-containing medium was replaced with serum-free medium for 24 h, and the cells were either untreated or incubated with 100 nM insulin for 20 h; 1 µCi of [3H]thymidine (final concentration, 2.5 µM) was then added for 4 h at 37°C. The cells were washed three times with ice-cold PBS and incubated with 0.5 ml of ice-cold 10% trichloroacetic acid for 1 h. The acid-insoluble fraction was solubilized in 0.25 ml of 0.2 N NaOH-0.1% SDS, and the wells were rinsed one time with an additional 0.25 ml of NaOH-SDS. The rinses were pooled, and the incorporation of [3H]thymidine into DNA was determined by scintillation counting.
Glucose transport. Differentiated 3T3L1 adipocytes were placed in DMEM containing 25 mM glucose plus 0.1% bovine serum albumin for 2 h at 37°C. The cells were then washed with KRPH buffer (5 mM Na2HPO4, 20 mM HEPES [pH 7.4], 1 mM MgSO4, 1 mM CaCl2, 136 mM NaCl, 4.7 mM KCl, 1% bovine serum albumin) and either untreated or stimulated with 100 nM insulin for 30 min as described in the figure legends. Glucose transport was determined by incubation on ice for 4 min with 100 µM 2-deoxyglucose containing 1.0 µCi of 2-[3H]deoxyglucose in the absence or presence of 10 µM cytochalasin B. The reaction was stopped after 10 min by washing the cells with ice-cold PBS containing 10 µM cytochalasin B, followed by two additional washes with ice-cold PBS. The cells were then solubilized in 0.5 N NaOH, and aliquots were subjected protein concentration determination prior to scintillation counting.
Glycogen synthesis and lipogenesis. Glycogen synthesis and lipogenesis assays were performed as previously described (65). Briefly, the adenovirus-infected 3T3L1 adipocytes were serum starved for 3 h in Krebs-Ringer bicarbonate (pH 7.4) buffer supplemented with 2.5 mM glucose. The cells were washed once with PBS and incubated for 15 min with Krebs-Ringer bicarbonate without glucose followed by an additional 15 min in the presence of 100 nM insulin. The cells were then incubated for 1 h with 5 mM glucose (2.0 µCi of [14C]glucose) for 1 h at 37°C. The radioactivity incorporated into glycogen was determined by precipitation as previously described (27). Insulin-stimulated lipogenesis was determined by the addition of 5 mM glucose (0.125 µCi of [14C]glucose) for 1 h at 37°C. The assay was terminated by three washes with ice-cold PBS and harvesting the cells in 1 ml of PBS. The radioactivity incorporated into lipid was determined by an overnight extraction of the PBS-harvested cells with Betafluor scintillation fluid (National Diagnostics, Manville, N.J.).
RESULTS
|
|
|---|
Recombinant adenovirus expression of K44A/dynamin. Dynamin is an approximately 100-kDa GTPase that has been shown to play an essential role in the internalization of constitutively recycling, growth factor-stimulated, and G-protein-coupled receptors (16, 58, 67). To examine the potential role of dynamin in insulin receptor endocytosis, we used recombinant adenoviruses, an approach which allows for the efficient expression of proteins into a variety of cell backgrounds.
Initially, we assessed the ability of a recombinant adenovirus to express K44A/dynamin in the rat hepatoma H4IIE cell line. Control cells and cells infected with recombinant adenoviruses encoding either LacZ or an HA-tagged GTPase-deficient (K44A) dynamin I mutant were immunoblotted for the presence of the dynamin I and dynamin II isoforms (Fig. 1). H4IIE cells primarily express the ubiquitous dynamin II isoform, which was not significantly affected by infection with the LacZ- or K44A/dynamin-containing adenoviruses (Fig. 1A). As expected, infection with the K44A/dynamin adenovirus resulted in a marked expression of the dynamin I isoform as detected with an antibody that cross-reacts with both dynamin I and dynamin II (Fig. 1B). Due to the high-level expression of K44A/dynamin I, the presence of dynamin II in the control and LacZ adenovirus-infected cells was not apparent at this exposure (Fig. 1B, lanes 1 and 2). To ensure that the 100-kDa dynamin-reactive protein was, in fact, due to adenovirus infection, we also immunoblotted these cell extracts with the HA-specific antibody 12CA5 (Fig. 1C). As expected, the 12CA5 antibody reacted only with a 100-kDa protein in extracts isolated from the K44A/dynamin adenovirus-infected cells (Fig. 1C). Neither cells infected with the LacZ-encoding adenovirus nor those infected with the K44A/dynamin mutant had any detectable change in the overall cell morphology (data not shown).
|
K44A/dynamin inhibits endocytosis of both transferrin and insulin receptors. It has been established that the transferrin receptor mediates the endocytosis of transferrin through a clathrin- and dynamin-dependent internalization mechanism (16). Therefore, to ensure that K44A/dynamin functioned in a dominant-interfering manner in H4IIE cells, we compared the rates and extents of transferrin internalization in cells infected with the adenoviruses encoding LacZ and K44A/dynamin (Fig. 2A). In the LacZ-expressing cells, approximately 70% of the cell surface transferrin receptor underwent endocytosis by 30 min. This value was essentially identical to that for the uninfected control cells (data not shown). In contrast, expression of the GTPase-deficient K44A/dynamin resulted in only 20% of the cell surface transferrin receptors being internalized. Similarly, expression of LacZ had no effect on insulin-stimulated endocytosis of the insulin receptor, with approximately 60 to 70% internalized within 30 min. However, expression of K44A/dynamin resulted in only 5% of the cell surface insulin receptors internalized within 30 min (Fig. 2B).
|
Cell surface insulin receptors autophosphorylate and tyrosine
phosphorylate IRS1.
Previously it has been suggested that the
endosome-localized insulin receptor may be responsible for mediating
insulin-dependent biological responses (12, 18, 31). We
therefore examined the insulin receptor signaling characteristics in
the H4IIE cells in which insulin receptor endocytosis was
inhibited. Insulin receptor immunoprecipitation followed by
phosphotyrosine immunoblotting demonstrated the typical
insulin-stimulated tyrosine autophosphorylation of the insulin receptor
subunit (Fig. 3A, lanes 1 and 2).
Insulin stimulation of K44A/dynamin adenovirus-infected cells also
resulted in a similar extent of
-subunit tyrosine phosphorylation
(Fig. 3A, lanes 3 and 4). The slightly lower extent of insulin receptor autophosphorylation in the K44A/dynamin- versus LacZ-expressing cells
was due to the small differences in immunoprecipitation as assessed by
-subunit immunoblotting of the insulin receptor immunoprecipitates
(Fig. 3A, lanes 5 to 8).
|
|
Receptor internalization is required for maximal activation of the PI 3-kinase but not the Akt kinase. In parallel to the Shc pathway predominantly mediating ERK activation, IRS1 couples to PI 3-kinase, which has been implicated in several biological responses, including mitogenesis, inhibition of apoptosis, and vesicular trafficking (21, 23, 54). To assess the ability of the cell surface insulin receptors to induce association and activation of the PI 3-kinase, we immunoprecipitated cell extracts with both phosphotyrosine- and IRS1-specific antibodies (Fig. 5). In the absence of insulin, there was essentially no PI 3-kinase activity found in either phosphotyrosine or IRS1 immunoprecipitates (Fig. 5A, lanes 1, 3, 5, and 7). In contrast, insulin stimulation of the LacZ adenovirus-infected cells resulted in a substantial amount of PI 3-kinase activity in these immunoprecipitates (Fig. 5A, lanes 2, 4, 6, and 8). Although there was a considerable PI 3-kinase activity that was also immunoprecipitated in the K44A/dynamin-expressing cells (Fig. 5A, lanes 4 and 8), this was significantly less than the activity immunoprecipitated from the LacZ-infected cells (Fig. 5A; compare lane 2 with lane 4 and lane 6 with lane 8). Quantitation of multiple PI 3-kinase assays from both phosphotyrosine and IRS1 immunoprecipitates demonstrated that approximately 50% of the insulin-stimulated PI 3-kinase activity was immunoprecipitated from the K44A/dynamin-expressing cells compared to the LacZ adenovirus-infected cells (Fig. 5B). Similarly, examination of the insulin dose response relationship between the LacZ and K44A/dynamin adenovirus-infected cells demonstrated a reduction in the maximal amount of IRS1-precipitable PI 3-kinase activity (Fig. 5C; compare lanes 1 to 5 with lanes 6 to 10).
|
|
|
Expression of K44A/dynamin enhances basal AIB uptake, glycogen synthesis, and lipogenesis. In the H4IIE hepatoma cell line, insulin stimulates amino acid uptake, which can be determined using the amino acid analog AIB as a measure of system A transport (38). Consistent with previous findings (34), insulin stimulation resulted in an approximate twofold increase of AIB uptake in the LacZ adenovirus-infected cells (Fig. 8A). However, expression of K44A/dynamin resulted in an approximate twofold increase in AIB uptake in the basal unstimulated state (Fig. 8A). Nevertheless, insulin stimulation induced a further increase which appeared to be additive with the effect of K44A/dynamin (Fig. 8A). Thus, the AIB system A amino acid transporter appears to accumulate on the H4IIE cell surface to higher steady-state level in the absence of dynamin-dependent endocytosis. In contrast, insulin stimulation of DNA synthesis as determined by thymidine incorporation was not significantly different between the LacZ- and K44A/dynamin-infected cells (Fig. 8B).
|
-subunit
autophosphorylation or IRS1 tyrosine phosphorylation (data not shown).
However, in the absence of insulin, there was a twofold elevation in
glucose transport without any significant effect on the extent of
insulin stimulation (Fig. 9A). The
expression of K44A/dynamin also resulted in enhanced glycogen synthesis
compared to the LacZ adenovirus-infected cells (Fig. 9B). In addition,
insulin was fully capable of stimulating glycogen synthesis in both the
Lac and K44A/dynamin adenovirus-infected cells (Fig. 9B). Furthermore,
expression of K44A/dynamin in the 3T3L1 adipocytes resulted in
increased basal lipogenesis which remained fully responsive to insulin
stimulation (Fig. 9C). These data demonstrate that increased glycogen
synthesis and lipogenesis induced by K44A/dynamin expression result
from the elevation of glucose transport, which is the rate-limiting
step under basal conditions. More importantly, inhibition of insulin
receptor internalization by K44A/dynamin expression did not impair the
signal transduction pathways leading to any of these biological
responses.
|
DISCUSSION
|
|
|---|
Similar to many cell surface receptors, the insulin receptor is
internalized into intracellular vesicular compartments following ligand
binding and tyrosine kinase activation (3, 28, 35, 37).
Recent studies have begun to examine the structural determinants required for insulin receptor endocytosis (2, 4, 5, 7, 8, 13, 24,
25). It is generally accepted that insulin receptor kinase
tyrosine autophosphorylation in conjunction with the dileucine motif
located in the juxtamembrane domain of the
subunit is essential for
insulin-mediated endocytosis (5, 25). However, the
identification of the functional tyrosine autophosphorylation sites
involved in this process has been enigmatic. Multiple studies
expressing various insulin receptor mutants in the juxtamembrane domain
have provided evidence both for and against the involvement of
consensus GPLY and NPEY tyrosine-based internalization motifs (2,
5, 7, 8, 13). Similarly, several studies have reported evidence
both for and against clathrin-mediated endocytosis of the insulin
receptor (40, 50, 51).
To address these issues, we examined the role of dynamin in insulin receptor internalization. Previous studies have demonstrated that dynamin plays a critical role in clathrin-mediated endocytosis. Dynamin appears to associate with clathrin-coated pits through its association with the adapter protein amphiphysin and the AP2 adapter complex (59). Once localized to coated pits, dynamin forms a ring structure or collar which is thought to pinch off coated vesicles (61). Although it is not clear whether dynamin itself is the so-called pinchase, dynamin GTPase activity is essential for the subsequent formation of clathrin-coated vesicles (60). Thus, expression of a GTPase-defective dynamin mutant results in a dominant-interfering phenotype by competing with endogenous dynamin and thereby preventing formation of the endocytic coated vesicles (57).
Using a dominant-interfering mutant of dynamin I (K44A/dynamin), we have observed an inhibition of both insulin and transferrin receptor endocytosis. This finding is consistent with previously published results which demonstrate that the transferrin receptor is internalized through a dynamin- and clathrin-dependent mechanism (16). Our observation that K44A/dynamin inhibits insulin receptor internalization in the same manner as the transferrin receptor is consistent with both receptors utilizing a dynamin- and clathrin-dependent pathway.
In addition to the sequestration of the insulin receptor into
clathrin-coated pits, the physiological role of ligand-mediated endocytosis has long been debated in the field of insulin receptor signaling. Controversy has centered around whether the endocytic process is primarily a means for inactivating the insulin receptor and/or for localizing the kinase-activated insulin receptor to appropriate signaling molecules (12, 18, 26, 31, 35). Therefore we examined the ability of the cell surface insulin receptors
to interact with a variety of established downstream effectors. Our
data demonstrate that inhibition of insulin receptor endocytosis had no
significant effect on the overall extent of
-subunit
autophosphorylation or IRS1 tyrosine phosphorylation. These results are
consistent with those of two previous studies in which inhibition of
insulin receptor internalization inhibited by reduced temperature had
no effect on either receptor autophosphorylation or IRS1 tyrosine
phosphorylation (9, 26).
In contrast, we did observe a small reduction in Shc tyrosine phosphorylation which correlated with a reduction in the extent of ERK1 and ERK2 activation. There was an approximate 50% diminution in the insulin-stimulated association of PI 3-kinase with IRS1 which directly correlated with a 50% reduction in both IRS1- and phosphotyrosine-immunoprecipitated PI 3-kinase activity. It is possible that this was a result of differences in specific sites of IRS1 tyrosine phosphorylation, as there was no significant change in the total levels of either IRS1 or p85 expression. In any case, these data suggest that endocytic compartmentalization of the insulin receptor, and possibly IRS1, is a prerequisite for maximal PI 3-kinase activation.
Nevertheless, insulin was still capable of inducing a substantial activation of the PI 3-kinase in the absence of insulin receptor endocytosis. In this regard, several studies have indicated that Akt activation is mediated through a PI 3-kinase-dependent pathway (10, 11, 17, 53). The ability of insulin to fully activate the Akt kinase in the K44A/dynamin-expressing cells further suggests that the inhibition of insulin-stimulated PI 3-kinase activity was a functionally minor event. Although less likely, it remains possible that a specific subcellular pool of PI 3-kinase is directly responsible for Akt activation, and it is this pool of PI 3-kinase that is not affected by K44A/dynamin expression.
Ultimately, insulin signaling leads to increases in the cellular
storage of energy in the form of protein, lipid, and carbohydrate. Since the proximal insulin signaling events were only marginally altered by the inhibition of insulin receptor endocytosis, we anticipated that these endpoint biological responses would also be
essentially unaffected. As predicted, insulin was fully capable of
stimulating amino acid uptake and DNA synthesis in the K44A/dynamin adenovirus-infected H4IIE cells. Unexpectedly, inhibition of
dynamin-dependent endocytosis resulted in an enhanced basal uptake of
AIB, suggesting an increased number of AIB transporters at the cell
surface under these conditions. To determine if this was a more general
phenomenon, we attempted to determine the effect of K44A/dynamin on
insulin-stimulated glycogen synthesis and lipogenesis. However, in our
hands the H4IIE cells displayed a negligible insulin stimulation of
these activities. Therefore, we used the differentiated 3T3L1
adipocytes which are markedly responsive to insulin and also are
quantitatively infected by adenovirus (reference 21
and data not shown). In addition, essentially identical effects of
K44A/dynamin on insulin receptor
-subunit autophosphorylation, IRS1
and Shc tyrosine phosphorylation, and PI 3-kinase and Akt kinase
activation were observed (data not shown). In any case, insulin was
also fully effective in the stimulation of glucose transport, glycogen
synthesis, and lipogenesis. Expression of K44A/dynamin increased the
basal rate of glucose uptake, glycogen synthesis, and lipogenesis. The increases in glycogen synthesis and lipogenesis are most likely due to
the increased glucose uptake, which is the rate-limiting step in the
basal state. Consistent with this hypothesis, we have also observed
that expression of K44A/dynamin resulted in the cell surface
accumulation of the GLUT4 glucose transporter (unpublished data).
In summary, the data presented in this report demonstrate that insulin-stimulated insulin receptor internalization occurs through a dynamin-dependent, and hence clathrin-mediated, endocytic pathway. Although the insulin-stimulated kinase-activated insulin receptor was unable to localize to endosomes, there was only minor effects on substrate tyrosine phosphorylation and association/activation of several downstream effectors. Our results demonstrate that neither amino acid transport, DNA synthesis, glucose transport, glycogen synthesis, nor lipogenesis is dependent on insulin receptor endocytosis and that each is fully responsive when the insulin receptor remains localized to the plasma membrane.
ACKNOWLEDGMENTS
|
|
|---|
We thank Sandra Schmid for providing the cDNA for dynamin and Christopher Newgard for the adenovirus expression system.
This work was supported by research grants DK49012, DK33823, and DK25925 from the National Institutes of Health. B.P.C. is a recipient of a postdoctoral fellowship award from the Juvenile Diabetes Foundation International.
FOOTNOTES
* Corresponding author. Mailing address: Department of Physiology and Biophysics, The University of Iowa, Iowa City, IA 52242-1109. Phone: (319) 335-7823. Fax: (319) 335-7330. E-mail: Jeffrey-Pessin{at}UIOWA.EDU.
REFERENCES
|
|
|---|
| 1. | Allessi, D. R., M. Andjelkovic, B. Caudwell, P. Cron, N. Morrice, P. Cohen, and B. A. Hemmings. 1996. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15:6541-6551[Medline]. |
| 2. |
Backer, J. M.,
C. R. Kahn,
D. A. Cahill,
A. Ullrich, and M. F. White.
1990.
Receptor-mediated internalization of insulin requires a 12-amino acid sequence in the juxtamembrane region of the insulin receptor beta-subunit.
J. Biol. Chem.
265:16450-16454 |
| 3. |
Backer, J. M.,
C. R. Kahn, and M. F. White.
1989.
Tyrosine phosphorylation of the insulin receptor during insulin-stimulated internalization in rat hepatoma cells.
J. Biol. Chem.
264:1694-1701 |
| 4. |
Backer, J. M.,
S. E. Shoelson,
E. Haring, and M. F. White.
1991.
Insulin receptors internalize by a rapid, saturable pathway requiring receptor autophosphorylation and an intact juxtamembrane region.
J. Cell Biol.
115:1535-1545 |
| 5. |
Backer, J. M.,
S. E. Shoelson,
M. A. Weiss,
Q. X. Hua,
R. B. Cheatham,
E. Haring,
D. C. Cahill, and M. F. White.
1992.
The insulin receptor juxtamembrane region contains two independent tyrosine/beta-turn internalization sequences.
J. Cell Biol.
118:831-839 |
| 6. | Becker, T. C., R. J. Noel, W. S. Coats, A. M. Gomez-Foix, T. Alam, R. D. Gerard, and C. B. Newgard. 1994. Use of recombinant adenovirus for metabolic engineering of mammalian cells. Methods Cell Biol. 43:161-189. |
| 7. | Berhanu, P., C. Anderson, D. R. Paynter, and W. M. Wood. 1995. The amino acid sequence GPLY is not necessary for normal endocytosis of the human insulin receptor B isoform. Biochem. Biophys. Res. Commun. 209:730-738[Medline]. |
| 8. |
Berhanu, P.,
R. H. Ibrahim-Schneck,
C. Anderson, and W. M. Wood.
1991.
The NPEY sequence is not necessary for endocytosis and processing of insulin-receptor complexes.
Mol. Endocrinol.
5:1827-1835 |
| 9. |
Biener, Y.,
R. Feinstein,
M. Mayak,
Y. Kaburagi,
T. Kadowaki, and Y. Zick.
1996.
Annexin II is a novel player in insulin signal transduction. Possible association between annexin II phosphorylation and insulin receptor internalization.
J. Biol. Chem.
271:29489-29496 |
| 10. | Bos, J. L. 1995. A target for phosphoinositide 3-kinase: Akt/PKB. Trends Biochem. Sci. 20:441-442[Medline]. |
| 11. | Burgering, B. M., and P. J. Coffer. 1995. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376:599-602[Medline]. |
| 12. |
Burgess, J. W.,
I. Wada,
N. Ling,
M. N. Khan,
J. J. M. Bergeron, and B. I. Posner.
1992.
Decrease in -subunit phosphotyrosine correlates with internalization and activation of the endosomal insulin receptor kinase.
J. Biol. Chem.
267:10077-10086 |
| 13. |
Carpentier, J. L.,
J. P. Paccaud,
J. Backer,
A. Gilbert,
L. Orci, and C. R. Kahn.
1993.
Two steps of insulin receptor internalization depend on different domains of the beta-subunit.
J. Cell Biol.
122:1243-1252 |
| 14. | Ceresa, B. P., and J. E. Pessin. 1998. Insulin regulation of the Ras activation/inactivation cycle. Mol. Cell. Biochem. 182:23-29[Medline]. |
| 15. | Damke, H. 1996. Dynamin and receptor-mediated endocytosis. FEBS Lett. 389:48-51[Medline]. |
| 16. |
Damke, H.,
T. Baba,
D. E. Warnock, and S. L. Schmid.
1994.
Induction of mutant dynamin specifically blocks endocytic coated vesicle formation.
J. Cell Biol.
127:915-934 |
| 17. |
Datta, K.,
A. Bellacosa,
T. O. Chan, and P. N. Tsichlis.
1996.
Akt is a direct target of the phosphatidylinositol 3-kinase. Activation by growth factors, v-src and v-Ha-ras, in Sf9 and mammalian cells.
J. Biol. Chem.
271:30835-30839 |
| 18. | diGugielmo, G. M., P. C. Baass, W. Ou, B. I. Posner, and J. J. M. Bergeron. 1994. Compartmentalization of SHC, GRB2 and mSOS, and hyperphosphorylation of Raf-1 by EGF but not insulin in liver parenchyma. EMBO J. 13:4269-4277[Medline]. |
| 19. | Franke, T. F., D. R. Kaplan, and L. C. Cantley. 1997. PI3K: downstream AKTion blocks apoptosis. Cell 88:435-437[Medline]. |
| 20. |
Franke, T. F.,
D. R. Kaplan,
L. C. Cantley, and A. Toker.
1997.
Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate.
Science
275:665-668 |
| 21. | Frevert, E. U., and B. B. Kahn. 1997. Differential effects of constitutively active phosphatidylinositol 3-kinase on glucose transport, glycogen synthase activity, and DNA synthesis in 3T3-L1 adipocytes. Mol. Cell. Biol. 17:190-198[Abstract]. |
| 22. | Grigliatti, T. A., L. Hall, R. Rosenbluth, and D. T. Suzuki. 1973. Temperature-sensitive mutations in Drosophila melanogaster. XIV. A selection of immobile adults. Mol. Gen. Genet. 120:107-114[Medline]. |
| 23. |
Hadari, Y. R.,
E. Tzahar,
O. Nadiv,
P. Rothenberg,
C. T. Roberts, Jr.,
D. LeRoith,
Y. Yarden, and Y. Zick.
1992.
Insulin and insulinomimetic agents induce activation of phosphatidylinositol 3'-kinase upon its association with pp185 (IRS-1) in intact rat livers.
J. Biol. Chem.
267:17483-17486 |
| 24. |
Haft, C. R.,
R. D. Klausner, and S. I. Taylor.
1994.
Involvement of dileucine motifs in the internalization and degradation of the insulin receptor.
J. Biol. Chem.
269:26286-26294 |
| 25. |
Hamer, I.,
C. R. Haft,
J. P. Paccaud,
C. Maeder,
S. Taylor, and J. L. Carpentier.
1997.
Dual role of a dileucine motif in insulin receptor endocytosis.
J. Biol. Chem.
272:21685-21691 |
| 26. |
Heller-Harrison, R. A.,
M. Morin, and M. P. Czech.
1995.
Insulin regulation of membrane associated insulin receptor substrate 1.
J. Biol. Chem.
270:24442-24450 |
| 27. | Hess, S. L., C. R. Suchin, and A. R. Saltiel. 1991. The specific protein phosphatase inhibitor okadaic acid differentially mediates insulin action. J. Cell. Biochem. 45:374-380[Medline]. |
| 28. | Jachen, A., J. Hays, and M. Lee. 1989. Kinetics of insulin internalization and processing in adipocytes: effects of insulin concentration. J. Cell. Physiol. 141:527-534[Medline]. |
| 29. | Jose, M., J. A. Biosca, R. Trujillo, and E. Itarte. 1993. Characterization of the hepatic insulin receptor undergoing internalization through clatherin-coated vesicles and endosomes. FEBS Lett. 334:286-288[Medline]. |
| 30. |
Kao, A. W.,
S. B. Waters,
S. Okada, and J. E. Pessin.
1997.
Insulin stimulates the phosphorylation of the 66- and 52-kilodalton Shc isoforms by distinct pathways.
Endocrinology
138:2474-2480 |
| 31. |
Khan, M. N.,
G. Baquiran,
C. Brule,
J. Burgess,
B. Foster,
J. J. M. Bergeron, and B. I. Posner.
1989.
Internalization and activation of the rat liver insulin receptor kinase in vivo.
J. Biol. Chem.
264:12931-12940 |
| 32. |
Khan, M. N.,
S. Savoie,
J. J. Bergeron, and B. I. Posner.
1986.
Characterization of rat liver endosomal fractions. In vivo activation of insulin-stimulable receptor kinase in these structures.
J. Biol. Chem.
261:8462-8472 |
| 33. | Klippel, A., W. M. Kavanaugh, D. Pot, and L. T. Williams. 1997. A specific product of phosphatidylinositol 3-kinase directly activates the protein kinase Akt through its pleckstin homology domain. Mol. Cell. Biol. 17:338-344[Abstract]. |
| 34. |
Krett, N. L.,
J. H. Heaton, and T. D. Gelehrter.
1987.
Mediation of insulin-like growth factor actions by the insulin receptor in H-35 rat hepatoma cells.
Endocrinology
120:401-408 |
| 35. |
Kublaoui, B.,
J. Lee, and P. Pilch.
1995.
Dynamics of signaling during insulin-stimulated endocytosis of its receptor in adipocytes.
J. Biol. Chem.
270:59-65 |
| 36. |
Lamb, J. E.,
F. Ray,
J. H. Ward,
J. P. Kushner, and J. Kaplan.
1983.
Internalization and subcellular localization of transferrin and transferrin receptors in HeLa cells.
J. Biol. Chem.
258:8751-8758 |
| 37. |
Levy, J. R., and J. M. Olefsky.
1987.
The trafficking and processing of insulin and insulin receptors in cultured rat hepatocytes.
Endocrinology
121:2075-2086 |
| 38. | Lin, G., J. I. McCormick, and R. M. Johnstone. 1994. Differentiation of two classes of "A" system amino acid transporters. Arch. Biochem. Biophys. 312:308-315[Medline]. |
| 39. |
Liu, J.-P., and P. J. Robinson.
1995.
Dynamin and endocytosis.
Endocr. Rev.
16:590-607 |
| 40. | McClain, D. A., and J. M. Olefsky. 1988. Evidence of two independent pathways of insulin-receptor internalization in hepatocytes and hepatoma cells. Diabetes 37:806-815[Abstract]. |
| 41. | McClure, S. J., and P. J. Robinson. 1996. Dynamin, endocytosis and intracellular signalling. Mol. Membr. Biol. 13:189-215[Medline]. |
| 42. | Mellman, I. 1996. Endocytosis and molecular sorting. Annu. Rev. Cell Dev. Biol. 12:575-625. [Medline] |
| 43. |
Mothe, I., and E. V. Obberghen.
1996.
Phosphorylation of insulin receptor substrate-1 on multiple serine residues, 612, 632, 662, and 731, modulates insulin action.
J. Biol. Chem.
271:11222-11227 |
| 44. |
Moule, S. K.,
G. I. Welsh,
N. J. Edgell,
E. J. Foulstone,
C. G. Proud, and R. M. Denton.
1997.
Regulation of protein kinase B and glycogen synthase kinase-3 by insulin and -adrenergic agonist in rat epididymal fat cells.
J. Biol. Chem.
272:7713-7719 |
| 45. |
Mukherjee, S.,
R. Ghosh, and F. Maxfield.
1997.
Endocytosis.
Physiol. Rev.
77:759-803 |
| 46. | Myers, M. G., X. J. Sun, and M. F. White. 1994. The IRS-1 signaling system. Trends Biochem. Sci. 19:289-293[Medline]. |
| 47. |
Okada, S.,
K. Yamauchi, and J. E. Pessin.
1995.
Shc isoform-specific tyrosine phosphorylation by the insulin and epidermal growth factor receptors.
J. Biol. Chem.
270:20737-20741 |
| 48. | Olson, A. L., J. B. Knight, and J. E. Pessin. 1997. Syntaxin 4, VAMP2, and/or VAMP3/cellubrevin are functional target membrane and vesicle SNAP receptors for insulin-stimulated GLUT4 translocation in adipocytes. Mol. Cell. Biol. 17:2425-2435[Abstract]. |
| 49. | Pastan, I. H., and M. C. Willingham. 1981. Receptor-mediated endocytosis of hormones in cultured cells. Annu. Rev. Physiol. 43:239-259[Medline]. |
| 50. |
Smith, R. M., and L. Jarett.
1990.
Differences in adenosine triphosphate dependency of receptor-mediated endocytosis of alpha 2-macroglobulin and insulin correlate with separate routes of ligand-receptor complex internalization.
Endocrinology
126:1551-1560 |
| 51. |
Smith, R. M.,
B. L. Seely,
N. Shah,
J. M. Olefsky, and L. Jarett.
1991.
Tyrosine kinase-defective insulin receptors undergo insulin-induced microaggregation but do not concentrate in coated pits.
J. Biol. Chem.
266:17522-17530 |
| 52. | Sorkin, A., and C. M. Waters. 1993. Endocytosis of growth factor receptors. Bioessays 15:375-382[Medline]. |
| 53. |
Stokoe, D.,
L. R. Stephens,
T. Copeland,
P. R. Gaffney,
C. B. Reese,
G. F. Painter,
A. B. Holmes,
F. McCormick, and P. T. Hawkins.
1997.
Dual role of phosphatidylinositol-3,4,5-triphosphate in the activation of protein kinase B.
Science
277:567-570 |
| 54. | Tsakiridis, T., H. E. McDowell, T. Walker, C. P. Downes, H. S. Hundal, M. Vranic, and A. Klip. 1995. Multiple roles of phosphatidylinositol 3-kinase in regulation of glucose transport, amino acid transport, and glucose transporters in L6 skeletal muscle cells. Endocrinology 136:4315-4322[Abstract]. |
| 55. | Turinsky, J., G. W. Nagel, J. S. Elmendorf, A. Damrau-Abney, and T. R. Smith. 1996. Sphingomyelinase stimulates 2-deoxyglucose uptake by skeletal muscle. Biochem. J. 313:215-222. |
| 56. |
Urrutia, R.,
J. R. Henley,
T. Cook, and M. A. McNiven.
1997.
The dynamins: redundant or distinct functions for an expanding family of related GTPases?
Proc. Natl. Acad. Sci. USA
94:377-384 |
| 57. |
vanderBliek, A. M.,
T. E. Redelmeier,
H. Damke,
E. J. Tisdale,
E. M. Meyerowitz, and S. L. Schmid.
1993.
Mutations in human dynamin block an intermediate stage in coated vesicle formation.
J. Cell Biol.
122:553-563 |
| 58. |
Viera, A. V.,
C. Lamaze, and S. L. Schmid.
1996.
Control of EGF receptor signaling by clatharin-mediated endocytosis.
Science
274:2086-2089 |
| 59. |
Wang, L. H.,
T. C. Sudhof, and R. G. Anderson.
1995.
The appendage domain of alpha-adaptin is a high affinity binding site for dynamin.
J. Biol. Chem.
270:10079-10083 |
| 60. |
Warnock, D. E.,
J. E. Hinshaw, and S. L. Schmid.
1996.
Dynamin self-assembly stimulates its GTPase activity.
J. Biol. Chem.
271:22310-22314 |
| 61. | Warnock, D. E., and S. L. Schmid. 1996. Dynamin GTPase, a force-generating molecular switch. Bioessays 18:885-893[Medline]. |
| 62. | Waters, S. B., and J. E. Pessin. 1996. Insulin receptor substrate 1 and 2: what a tangled web we weave. Trends Cell Biol. 6:1-4. [Medline] |
| 63. | White, M. F. 1994. The IRS-1 signaling system. Curr. Opin. Genet. Dev. 4:47-54[Medline]. |
| 64. | White, M. F., R. Maron, and C. R. Kahn. 1985. Insulin rapidly stimulates tyrosine phosphorylation of Mr-185,000 protein in intact cells. Nature 318:183-186[Medline]. |
| 65. |
Wiese, R. J.,
C. C. Mastick,
D. F. Lazar, and A. R. Saltiel.
1995.
Activation of mitogen-activated protein kinase and phosphatidylinositol 3'-kinase is not sufficient for the hormonal stimulation of glucose uptake, lipogenesis, or glycogen synthesis in 3T3-L1 adipocytes.
J. Biol. Chem.
270:3442-3446 |
| 66. |
Yamauchi, K., and J. E. Pessin.
1994.
Insulin receptor substrate-1 (IRS1) and Shc compete for a limited pool of Grb2 in mediating insulin downstream signaling.
J. Biol. Chem.
269:31107-31114 |
| 67. |
Zhang, J.,
S. S. G. Feruson,
L. S. Barak,
L. Menard, and M. G. Caron.
1996.
Dynamin and -arrestin reveal distinct mechanisms for G protein-coupled receptor internalization.
J. Biol. Chem.
271:18302-18305 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»